Stockreport

Atai Life Sciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

ATAI Life Sciences N.V. - Common Shares  (ATAI) 
US:NASDAQ Investor Relations: ir.atai.net.cn
PDF US$0.25 loss per share (improved from US$0.98 loss in FY 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period Atai Life Sciences E [Read more]